Internal Medicine · Pittsburgh, PA
NPI
1952364044
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4520 Penn Ave
Pittsburgh, PA, 15224
Phone (412) 681-4211
Groups this clinician bills Medicare through
Medicare paid, 2024
$355K
4,750 services
Medicare patients, 2024
372
Average age 77
Drug cost, 2024
$2.5M
32,408 prescriptions
Company payments, 2025
$4,301
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daljit Singh was code 99233 (hospital e&m - subsequent), 1,894 times for 193 patients. In total Daljit Singh billed 4,750 services in 58 codes, and Medicare paid $355K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-08-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 1,894 | 193 | $92.68 | $176K |
| 99214 Office E&M - Established | Office | 597 | 162 | $81.72 | $49K |
| 99232 Hospital E&M - Subsequent | Facility | 379 | 129 | $61.37 | $23K |
| 99223 Hospital E&M - Initial | Facility | 263 | 190 | $134.67 | $35K |
| 99308 SNF E&M | Facility | 188 | 19 | $51.49 | $9,681 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 132 | 19 | $0.76 | $100 |
| 99239 Hospital Discharge Management | Facility | 110 | 73 | $88.59 | $9,744 |
| 96372 Injection Administration | Office | 98 | 48 | $9.75 | $955 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 97 | 97 | $18.22 | $1,767 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 88 | 88 | $126.95 | $11K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 79 | 19 | $0.32 | $25.47 |
| 99215 Office E&M - Established | Office | 77 | 50 | $123.25 | $9,490 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 72 | 36 | $0.87 | $62.69 |
| G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 60 | 38 | $8.81 | $529 |
| G0008 Administration of influenza virus vaccine | Office | 57 | 56 | $29.40 | $1,676 |
By year: 2022 $334K for 7,392 services; 2023 $394K for 6,507 services; 2024 $355K for 4,750 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 32 | 25 | $9.52 | $305 |
| 36415 Venipuncture Blood Collection | 23 | 17 | $8.40 | $193 |
Medicare prescription drug claims, 2024
In 2024, the drug Daljit Singh prescribed most often to Medicare patients was Gabapentin, with 1,244 prescriptions and refills. In total Daljit Singh wrote 32,408 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 1,244 | 2,061 | 258 | $15K |
| Atorvastatin Calcium Generic | 981 | 2,030 | 258 | $13K |
| Levothyroxine Sodium Generic | 956 | 2,075 | 240 | $13K |
| Pantoprazole Sodium Generic | 899 | 1,884 | 284 | $11K |
| Rosuvastatin Calcium Generic | 818 | 2,010 | 237 | $11K |
| Amlodipine Besylate Generic | 809 | 1,661 | 213 | $5,751 |
| Furosemide Generic | 728 | 1,258 | 192 | $4,023 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 716 | 718 | 97 | $14K |
| Lorazepam Generic | 567 | 639 | 115 | $2,544 |
| Diclofenac Sodium Generic | 524 | 806 | 163 | $27K |
| Eliquis Apixaban | 515 | 595 | 96 | $275K |
| Valsartan Generic | 507 | 1,189 | 136 | $12K |
| Metoprolol Succinate Generic | 493 | 1,040 | 119 | $7,408 |
| Quetiapine Fumarate Generic | 488 | 672 | 104 | $4,162 |
| Tamsulosin Hcl Generic | 443 | 816 | 114 | $6,596 |
Brand drugs: 3,896 claims; generic drugs: 28,305 claims; opioid claims: 1,420.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daljit Singh $4,301 ($4,301 in general payments such as food, travel and fees) from 29 companies. The largest payer was GlaxoSmithKline, LLC. with $530.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 26 | $530 |
| Amgen Inc. AMGN | 27 | $491 |
| Abbvie Inc. ABBV | 23 | $408 |
| AstraZeneca Pharmaceuticals LP AZN | 20 | $379 |
| Lilly USA, LLC LLY | 20 | $332 |
| Novo Nordisk Inc NVO | 18 | $312 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $275 |
| Shield Therapeutics Inc STX.L | 9 | $180 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 15 | $176 |
| Astellas Pharma US Inc 4503.T | 11 | $169 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.